文献速递男科与性医学

阴茎硬结症胶原酶注射治疗成功的预测因素:多中心单臂研究列线图开发

Predictors of treatment success after collagenase Clostridium histolyticum injection for Peyronie's disease: development of a nomogram from a multicentre single-arm, non-placebo controlled clinical study.
PubMed 文献 · BJU Int · 2018-06-20

本研究纳入135例阴茎硬结症患者,构建预测胶原酶梭菌组织溶解酶(CCH)治疗成功的列线图。治疗成功定义为阴茎弯曲度(PC)较基线减少≥20°。基线PC、基底斑块、低钙化及高钙化是PC改善的显著预测因素,模型c-index为0.93。

要点

  • 基线PC较大、基底斑块位置的患者治疗成功机会更高。
  • 钙化(低或高)与PC改善负相关,OR分别为0.06和0.03。
  • 列线图模型区分度良好(c-index 0.93),可用于临床实践但需外部验证。

核心结论

  • 阴茎硬结症病程更长、基线PC更大及基底斑块位置的患者治疗成功机会更大。
  • 列线图模型区分度良好(c-index 0.93),可在外部验证前应用于临床实践。

研究设计与样本

  • 所有患者接受CCH治疗,治疗成功定义为PC较基线减少≥20°。

主要发现

  • 治疗后PC中位变化为-20.0°(P < 0.01),中位改善44(28.0-67.0)%。
  • 总体中位满意度评分为8.0(7.0-9.0),治疗有效率为57.04%(77例)。
  • 基线PC(OR 1.14;P < 0.01)、基底斑块(OR 64.27;P < 0.01)、低钙化(OR 0.06;P < 0.01)和高钙化(OR 0.03;P < 0.01)是PC改善的显著预测因素。

关键数值与推荐

  • 治疗成功定义为PC较基线减少≥20°。
  • 高满意度任意定义为满意度评分≥8(1-10分)。
  • 钙化分级:无钙化、病灶周围低钙化、高钙化。
  • 列线图模型c-index为0.93。

临床怎么用

  • 可利用基线PC、斑块位置及钙化程度预测CCH治疗成功概率,辅助患者咨询与治疗决策。
  • 列线图在外部验证前可暂用于临床实践。

局限性

  • 单臂、非安慰剂对照设计,缺乏对照组。
  • 样本量有限(135例),列线图需外部验证。
  • 治疗成功定义(PC减少≥20°)和满意度阈值(≥8)为研究设定,可能影响普适性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To build a nomogram able to predict treatment success after collagenase Clostridium histolyticum (CCH) for Peyronie's disease (PD). MATERIALS AND METHODS: Between November 2016 and November 2017, we enrolled 135 patients with PD into a multicentre single-arm prospective study. All patients enrolled received CCH treatment. Success of therapy was defined as a decrease in penile curvature (PC) of ≥20° from baseline. Treatment satisfaction was assessed using a scale from 1 to 10, and high satisfaction was arbitrarily defined as a score of ≥8. Calcification level was classified as: absence of calcification; low perilesional calcification; and high calcification. RESULTS: The median (interquartile range [IQR]) patient age was 56.0 (45.0-65.0) years and the median (IQR) was PC was 30 (30.0-60.0)°. After the treatment protocol, we observed a significant median change in PC of -20.0° (P < 0.01). The median (IQR) PC improvement was 44 (28.0-67.0)%. Overall median (IQR) satisfaction score was 8.0 (7.0-9.0). Treatment efficacy was reported in a total of 77 patients (57.04%). When analysing factors associated with PC improvement after treatment, we found that baseline PC (odds ratio [OR] 1.14; P < 0.01), basal plaque (OR 64.27; P < 0.01), low calcification (OR 0.06; P < 0.01) and high calcification (OR 0.03; P < 0.01) were significant predictors of PC improvement. The c-index for the model was 0.93. CONCLUSIONS: Patients with longer PD duration, greater baseline PC and basal plaque location had a greater chance of treatment success. These results could be applied to clinical practice before external validation of our nomogram.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Cocci A, Russo GI, Briganti A, et al. Predictors of treatment success after collagenase Clostridium histolyticum injection for Peyronie's disease: development of a nomogram from a multicentre single-arm, non-placebo controlled clinical study. BJU Int. 2018. PMID: 29791971. doi:10.1111/bju.14410

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。